An Act relative to Topical Steroid Withdrawal Syndrome
Generates a plain-language summary of the bill text and history.
| Date | Branch | Action |
|---|---|---|
| 2/11/2026 | House | Bill reported favorably by committee and referred to the committee on House Ways and Means |
| 11/26/2025 | Joint | Hearing scheduled for 12/08/2025 from 09:00 AM-05:00 PM in Written Testimony Only |
| 10/30/2025 | Senate | Senate concurred |
| 10/27/2025 | House | Reported, referred to the committee on Joint Rules, reported, rules suspended and referred to the committee on Public Health |
| 3/27/2025 | House | Referred to the committee on House Rules |
| Committee | Recommendation | Vote |
|---|---|---|
| H33 | Suspend Rules | — |
| J16 | Favorable | 1 entries |
Chapter 111 of the General Laws is hereby amended by adding the following section:-
There is hereby established a commission to research topical steroid addiction and Topical Steroid Withdrawal Syndrome, a severe and debilitating condition that can result from intentional or unintentional exposure to topical steroids. The commissioner shall have 1 member who is a representative of the department and 7 members appointed by the governor, 1 of whom shall be a dermatologist, 1 of whom shall be a licensed pediatrician, 1 of whom shall be a licensed pharmacist, 1 of whom shall be a licensed immunologist and 3 of whom shall be individuals or parents who have been impacted by Topical Steroid Withdrawal Syndrome. The special commission may conduct public hearings, forums, or meetings to gather information regarding medical protocols for prevention, early detection and treatment of Topical Steroid Withdrawal Syndrome and generate awareness of the condition among health care providers, patients and consumers when prescribing medications. Annually, on or before June 30, the commission shall submit a report to the governor and the clerks of the house of representatives and the senate who shall forward the same to the joint committee on public health, along with recommendations, if any, together with drafts of legislation necessary to carry out those recommendations into effect. The special commission may file such interim reports and recommendations as it considers appropriate.
Chapter 111 of the General Laws is hereby amended by adding the following section:- Section 245. There is hereby established a commission to research topical steroid addiction and Topical Steroid Withdrawal Syndrome, a severe and debilitating condition that can result from intentional or unintentional exposure to topical steroids. The commissioner shall have 1 member who is a representative of the department and 7 members appointed by the governor, 1 of whom shall be a dermatologist, 1 of whom shall be a licensed pediatrician, 1 of whom shall be a licensed pharmacist, 1 of whom shall be a licensed immunologist and 3 of whom shall be individuals or parents who have been impacted by Topical Steroid Withdrawal Syndrome. The special commission may conduct public hearings, forums, or meetings to gather information regarding medical protocols for prevention, early detection and treatment of Topical Steroid Withdrawal Syndrome and generate awareness of the condition among health care providers, patients and consumers when prescribing medications. Annually, on or before June 30, the commission shall submit a report to the governor and the clerks of the house of representatives and the senate who shall forward the same to the joint committee on public health, along with recommendations, if any, together with drafts of legislation necessary to carry out those recommendations into effect. The special commission may file such interim reports and recommendations as it considers appropriate.